Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GinOnc-ECT: Electrochemotherapy for vulvar precancerous squamous lesions and Paget's disease
2024-518796-65-00Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin and cisplatin in vulvar intraepithelial neoplasia (VIN), vulvar squamous cell carcinoma (VSCC) and Extramammary Paget disease of the vulva (EMPDV), sponsored by Policlinico Gemelli. Primary endpoint: Histological pathological response at 30 days. Started Nov 2024; status: completed.
02
Drugs
bleomycincisplatin
03
Conditions
vulvar intraepithelial neoplasia (VIN)vulvar squamous cell carcinoma (VSCC)Extramammary Paget disease of the vulva (EMPDV)
Beyond the preview
Go deeper on 2024-518796-65-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518796-65-00.